146 related articles for article (PubMed ID: 19450180)
1. Role of the MTHFR polymorphisms in cancer risk modification and treatment.
Kim YI
Future Oncol; 2009 May; 5(4):523-42. PubMed ID: 19450180
[TBL] [Abstract][Full Text] [Related]
2. Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate.
Sohn KJ; Croxford R; Yates Z; Lucock M; Kim YI
J Natl Cancer Inst; 2004 Jan; 96(2):134-44. PubMed ID: 14734703
[TBL] [Abstract][Full Text] [Related]
3. 5,10-Methylenetetrahydrofolate reductase polymorphisms and pharmacogenetics: a new role of single nucleotide polymorphisms in the folate metabolic pathway in human health and disease.
Kim YI
Nutr Rev; 2005 Nov; 63(11):398-407. PubMed ID: 16370225
[TBL] [Abstract][Full Text] [Related]
4. C677T and A1298C MTHFR polymorphisms, a challenge for antifolate and fluoropyrimidine-based therapy personalisation.
De Mattia E; Toffoli G
Eur J Cancer; 2009 May; 45(8):1333-51. PubMed ID: 19144510
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan.
Chou YC; Wu MH; Yu JC; Lee MS; Yang T; Shih HL; Wu TY; Sun CA
Carcinogenesis; 2006 Nov; 27(11):2295-300. PubMed ID: 16777985
[TBL] [Abstract][Full Text] [Related]
6. Folate-related genes and the risk of tobacco-related cancers in Central Europe.
Hung RJ; Hashibe M; McKay J; Gaborieau V; Szeszenia-Dabrowska N; Zaridze D; Lissowska J; Rudnai P; Fabianova E; Mates I; Foretova L; Janout V; Bencko V; Chabrier A; Moullan N; Canzian F; Hall J; Boffetta P; Brennan P
Carcinogenesis; 2007 Jun; 28(6):1334-40. PubMed ID: 17389614
[TBL] [Abstract][Full Text] [Related]
7. One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer.
Chen J; Gammon MD; Chan W; Palomeque C; Wetmur JG; Kabat GC; Teitelbaum SL; Britton JA; Terry MB; Neugut AI; Santella RM
Cancer Res; 2005 Feb; 65(4):1606-14. PubMed ID: 15735051
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes.
Wessels JA; de Vries-Bouwstra JK; Heijmans BT; Slagboom PE; Goekoop-Ruiterman YP; Allaart CF; Kerstens PJ; van Zeben D; Breedveld FC; Dijkmans BA; Huizinga TW; Guchelaar HJ
Arthritis Rheum; 2006 Apr; 54(4):1087-95. PubMed ID: 16572443
[TBL] [Abstract][Full Text] [Related]
9. Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case control study.
Suzuki T; Matsuo K; Hiraki A; Saito T; Sato S; Yatabe Y; Mitsudomi T; Hida T; Ueda R; Tajima K
Carcinogenesis; 2007 Aug; 28(8):1718-25. PubMed ID: 17468511
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate-induced mucositis in acute leukemia patients is not associated with the MTHFR 677T allele in Mexico.
Ruiz-Argüelles GJ; Coconi-Linares LN; Garcés-Eisele J; Reyes-Núñez V
Hematology; 2007 Oct; 12(5):387-91. PubMed ID: 17891601
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate toxicity and efficacy during the consolidation phase in paediatric acute lymphoblastic leukaemia and MTHFR polymorphisms as pharmacogenetic determinants.
D'Angelo V; Ramaglia M; Iannotta A; Crisci S; Indolfi P; Francese M; Affinita MC; Pecoraro G; Napolitano A; Fusco C; Oreste M; Indolfi C; Casale F
Cancer Chemother Pharmacol; 2011 Nov; 68(5):1339-46. PubMed ID: 21590445
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetic relevance of MTHFR polymorphisms.
Toffoli G; De Mattia E
Pharmacogenomics; 2008 Sep; 9(9):1195-206. PubMed ID: 18781847
[TBL] [Abstract][Full Text] [Related]
13. Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia.
Aplenc R; Thompson J; Han P; La M; Zhao H; Lange B; Rebbeck T
Cancer Res; 2005 Mar; 65(6):2482-7. PubMed ID: 15781665
[TBL] [Abstract][Full Text] [Related]
14. Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour behaviour in men.
Safarinejad MR; Shafiei N; Safarinejad S
Clin Oncol (R Coll Radiol); 2012 May; 24(4):269-81. PubMed ID: 21489764
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study.
Lin J; Spitz MR; Wang Y; Schabath MB; Gorlov IP; Hernandez LM; Pillow PC; Grossman HB; Wu X
Carcinogenesis; 2004 Sep; 25(9):1639-47. PubMed ID: 15117811
[TBL] [Abstract][Full Text] [Related]
16. Controversial roles of methylenetetrahydrofolate reductase polymorphisms and folate in breast cancer disease.
Bravatà V
Int J Food Sci Nutr; 2015 Feb; 66(1):43-9. PubMed ID: 25318348
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of methylenetetrahydrofolate reductase modifies response to methotrexate in mice.
Celtikci B; Leclerc D; Lawrance AK; Deng L; Friedman HC; Krupenko NI; Krupenko SA; Melnyk S; James SJ; Peterson AC; Rozen R
Pharmacogenet Genomics; 2008 Jul; 18(7):577-89. PubMed ID: 18551038
[TBL] [Abstract][Full Text] [Related]
18. Relationship between three polymorphisms of methylenetetrahydrofolate reductase (MTHFR C677T, A1298C, and G1793A) gene and risk of prostate cancer: a case-control study.
Safarinejad MR; Shafiei N; Safarinejad S
Prostate; 2010 Nov; 70(15):1645-57. PubMed ID: 20564317
[TBL] [Abstract][Full Text] [Related]
19. Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmö Diet and Cancer cohort.
Ericson U; Sonestedt E; Ivarsson MI; Gullberg B; Carlson J; Olsson H; Wirfält E
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1101-10. PubMed ID: 19336565
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East.
Siraj AK; Ibrahim M; Al-Rasheed M; Bu R; Bavi P; Jehan Z; Abubaker J; Murad W; Al-Dayel F; Ezzat A; El-Solh H; Uddin S; Al-Kuraya K
Ann Hematol; 2007 Dec; 86(12):887-95. PubMed ID: 17712558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
